Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.

Saved in:
Bibliographic Details
Title: Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.
Authors: Sester LS; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Galeeva I; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., de Castilhos J; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Borisov V; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Gambihler AK; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Kilian M; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA., Vonhören D; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Friedrich MJ; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Broad Institute of MIT and Harvard, Cambridge, MA., Poschet G; Metabolomics Core Technology Platform, Center for Organismal Studies, Heidelberg University, Heidelberg, Germany., Steiger S; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Chechenina A; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Lettau K; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Kohlberger CP; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Prokoph N; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Frenking J; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., John L; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Reichert P; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Mai EK; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Sauer S; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Weinhold N; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Platten M; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Cancer Research Center Hector Cancer Institute, University Medical Center Mannheim, Mannheim, Germany.; Helmholtz Institute of Translational Oncology, Mainz, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases, Heidelberg, Germany., Goldschmidt H; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany., Raab MS; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Stein-Thoeringer CK; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.; German Center for Infectious Diseases, Tuebingen, Germany.
Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3088-3093.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025018598